Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × ixazomib × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 24 Waldenstrom Macroglobulinemia 3 Immunoglobulin Light-chain Amyloidosis 3 Recurrence 2 Lymphoma, Mantle-Cell 2 Smoldering Multiple Myeloma 1 Sarcoma, Kaposi 1 Proteostasis Deficiencies 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm, Residual 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Carcinoma, Transitional Cell 1 Amyloidosis 1

Interventions

Cyclophosphamide 8 Biopsy 8 Specimen Handling 7 pembrolizumab 6 fludarabine 6 Whole-Body Irradiation 6 Magnetic Resonance Spectroscopy 6 Peripheral Blood Stem Cell Transplantation 5 Brentuximab Vedotin 5 fludarabine phosphate 4 duvelisib 4 Melphalan 4 10-propargyl-10-deazaaminopterin 4 ruxolitinib 3 X-Rays 3 Mycophenolic Acid 3 Immunoglobulin G 3 Gemcitabine 3 Disulfides 3 tazemetostat 2 sodium-iodide symporter 2 romidepsin 2 cemiplimab 2 belinostat 2 Sirolimus 2 Rituximab 2 Photons 2 Pharmacogenomic Variants 2 Nivolumab 2 Lenalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡